High-Dose Tirofiban

Bart Dawson, Debabrata Mukherjee, David J. Moliterno

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Original languageEnglish
Title of host publicationPharmacology in the Catheterization Laboratory
Number of pages4
StatePublished - Oct 30 2009


  • Acute coronary syndromes (ACS) undergoing PCI
  • Glycoprotein (GP) IIb/IIIa inhibitors in reducing cardiovascular ischemic event
  • High-dose tirofiban
  • Major adverse cardiovascular events (MACE) after PCI
  • Percutaneous coronary intervention (PCI)
  • TENACITY (Tirofiban Evaluation of Novel Dosing vs Abciximab with Clopidogrel and Inhibition of Thrombin) trial
  • Target vessel revascularization (TVR)
  • Tirofiban - reducing pharmaceutical cost of PCI relative to abciximab

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'High-Dose Tirofiban'. Together they form a unique fingerprint.

Cite this